Searched for
CHRONIC THERAPIES MARKET
Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerBiocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...09 Sep, 2026, 11.42 AM IST- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...09 Sep, 2026, 12.46 AM IST
- Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...08 Sep, 2026, 07.49 PM IST
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...06 Sep, 2026, 01.01 PM IST
- Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 marketsNovartis India plans acquisitions and deeper market penetration for future growth. The company will focus on five key therapy areas for exp...06 Sep, 2026, 10.49 AM IST
- Tough task: Staying invested in businesses while ignoring noise called Gulf war; 6 mid-cap stocks with upside potential of up to 23%Trying to time the market turns volatility into something that beats an investor twice: Once on the way down, and once on the way up. So, i...02 Sep, 2026, 09.57 PM IST
- Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...31 Aug, 2026, 06.18 PM IST
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...31 Aug, 2026, 04.12 PM IST
- Up to 407% returns! 12 recently listed stocks turn multibaggers as Nifty IPO index hits 52-week highThe Nifty IPO Index has hit a remarkable 52-week high, showcasing an impressive appetite from investors. Recently, twelve newly listed firm...27 Aug, 2026, 02.57 PM IST
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST
- GLP-1 demand stirs up hunger for obesity care talentDemand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...02 Aug, 2026, 06.07 AM IST
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...27 Jul, 2026, 12.52 PM IST
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...26 Jul, 2026, 02.45 PM IST
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...22 Jul, 2026, 03.00 PM IST
- RPG Life Sciences ties-up with Archerchem Healthcare to launch anti-inflammatory solution in IndiaRPG Life Sciences and Archerchem Healthcare have partnered to launch a new medication. This combination drug offers anti-inflammatory benef...13 Jul, 2026, 02.06 PM IST
- Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...17 Jun, 2026, 12.21 PM IST
- Chronic illness sees a spurt in business opportunity for pharma marketAccording to data from AIOCD, the Indian pharma market has grown at a compound annual growth rate of 3.3% in volume terms in the past five ...19 Nov, 2014, 05.42 AM IST
Load More
